Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.18
NAS:LHCG's Cash to Debt is ranked lower than
58% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. NAS:LHCG: 0.18 )
Ranked among companies with meaningful Cash to Debt only.
NAS:LHCG' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.5 Max: No Debt
Current: 0.18
Equity to Asset 0.63
NAS:LHCG's Equity to Asset is ranked higher than
71% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. NAS:LHCG: 0.63 )
Ranked among companies with meaningful Equity to Asset only.
NAS:LHCG' s Equity to Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.72 Max: 0.82
Current: 0.63
0.34
0.82
Interest Coverage 23.05
NAS:LHCG's Interest Coverage is ranked higher than
69% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 7.76 vs. NAS:LHCG: 23.05 )
Ranked among companies with meaningful Interest Coverage only.
NAS:LHCG' s Interest Coverage Range Over the Past 10 Years
Min: 18.3  Med: 102.82 Max: 713.45
Current: 23.05
18.3
713.45
F-Score: 4
Z-Score: 4.67
M-Score: -2.52
WACC vs ROIC
7.42%
10.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 7.53
NAS:LHCG's Operating margin (%) is ranked higher than
52% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 6.84 vs. NAS:LHCG: 7.53 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:LHCG' s Operating margin (%) Range Over the Past 10 Years
Min: -1.01  Med: 10.75 Max: 16.16
Current: 7.53
-1.01
16.16
Net-margin (%) 3.84
NAS:LHCG's Net-margin (%) is ranked lower than
56% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. NAS:LHCG: 3.84 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:LHCG' s Net-margin (%) Range Over the Past 10 Years
Min: -2.09  Med: 5.44 Max: 10.95
Current: 3.84
-2.09
10.95
ROE (%) 9.47
NAS:LHCG's ROE (%) is ranked lower than
51% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 9.67 vs. NAS:LHCG: 9.47 )
Ranked among companies with meaningful ROE (%) only.
NAS:LHCG' s ROE (%) Range Over the Past 10 Years
Min: -4.93  Med: 12.55 Max: 26.16
Current: 9.47
-4.93
26.16
ROA (%) 5.85
NAS:LHCG's ROA (%) is ranked higher than
61% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. NAS:LHCG: 5.85 )
Ranked among companies with meaningful ROA (%) only.
NAS:LHCG' s ROA (%) Range Over the Past 10 Years
Min: -3.51  Med: 9.49 Max: 20.02
Current: 5.85
-3.51
20.02
ROC (Joel Greenblatt) (%) 65.78
NAS:LHCG's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 18.74 vs. NAS:LHCG: 65.78 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:LHCG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4.82  Med: 63.16 Max: 147.21
Current: 65.78
-4.82
147.21
Revenue Growth (3Y)(%) 9.30
NAS:LHCG's Revenue Growth (3Y)(%) is ranked higher than
57% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. NAS:LHCG: 9.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:LHCG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.5  Med: 23.4 Max: 60.7
Current: 9.3
3.5
60.7
EBITDA Growth (3Y)(%) 8.80
NAS:LHCG's EBITDA Growth (3Y)(%) is ranked higher than
56% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. NAS:LHCG: 8.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:LHCG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -64.8  Med: 29 Max: 171.3
Current: 8.8
-64.8
171.3
EPS Growth (3Y)(%) 6.30
NAS:LHCG's EPS Growth (3Y)(%) is ranked lower than
52% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. NAS:LHCG: 6.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:LHCG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -21.4  Med: 27.9 Max: 112.8
Current: 6.3
-21.4
112.8
» NAS:LHCG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

LHCG Guru Trades in Q4 2015

Steven Cohen 75,600 sh (New)
Jim Simons 209,300 sh (+38.06%)
Chuck Royce Sold Out
Joel Greenblatt 52,320 sh (-37.41%)
» More
Q1 2016

LHCG Guru Trades in Q1 2016

Paul Tudor Jones 9,200 sh (New)
Jim Simons 299,500 sh (+43.10%)
Steven Cohen 42,100 sh (-44.31%)
Joel Greenblatt 11,887 sh (-77.28%)
» More
Q2 2016

LHCG Guru Trades in Q2 2016

Joel Greenblatt 38,935 sh (+227.54%)
Paul Tudor Jones Sold Out
Steven Cohen 31,700 sh (-24.70%)
Jim Simons 122,300 sh (-59.17%)
» More
Q3 2016

LHCG Guru Trades in Q3 2016

Paul Tudor Jones 6,900 sh (New)
Steven Cohen 44,900 sh (+41.64%)
Jim Simons 172,000 sh (+40.64%)
Joel Greenblatt 15,563 sh (-60.03%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:SGRY, NYSE:USPH, NAS:HWAY, NYSE:CYH, OTCPK:RLGHF, NAS:PRSC, NAS:PAHC, NAS:AFAM, OTCPK:MFCSF, NAS:ADUS, OTCPK:CMBGF, NAS:USMD, NYSE:AAC, NAS:AMED, NYSE:ADPT, AMEX:HLTH, NYSE:CCM, NYSE:QHC, NAS:BIOS, OTCPK:CATS » details
Traded in other countries:LH6.Germany,
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

LHC Group Inc was incorporated on February 9, 2005. The Company provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals (LTACHs). The Company through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operates in 30 states within the continental United States. The Company operates in three segments: home-based services, hospice services and facility-based services. In the home-based services segment, the Company provides home-based post-acute health care services through its home nursing and community-based agencies. Its service locations offer services, including skilled nursing, community-based nursing and companion services, non-skilled community-based services (CBS), medically-oriented social services and physical, occupational and speech therapy. The hospices segment provides end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. It offers services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The LTACH locations provide services to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company is subject to federal, state and local laws, which significantly affects its business.

Ratios

vs
industry
vs
history
P/E(ttm) 21.63
LHCG's P/E(ttm) is ranked higher than
62% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 25.07 vs. LHCG: 21.63 )
Ranked among companies with meaningful P/E(ttm) only.
LHCG' s P/E(ttm) Range Over the Past 10 Years
Min: 7.61  Med: 18.51 Max: 32.35
Current: 21.63
7.61
32.35
Forward P/E 19.84
LHCG's Forward P/E is ranked lower than
75% of the 53 Companies
in the Global Medical Care industry.

( Industry Median: 16.18 vs. LHCG: 19.84 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.63
LHCG's PE(NRI) is ranked higher than
63% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 25.14 vs. LHCG: 21.63 )
Ranked among companies with meaningful PE(NRI) only.
LHCG' s PE(NRI) Range Over the Past 10 Years
Min: 7.62  Med: 18.33 Max: 32.35
Current: 21.63
7.62
32.35
Price/Owner Earnings (ttm) 31.95
LHCG's Price/Owner Earnings (ttm) is ranked lower than
60% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 25.79 vs. LHCG: 31.95 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
LHCG' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.64  Med: 18.87 Max: 74.26
Current: 31.95
6.64
74.26
P/B 1.92
LHCG's P/B is ranked higher than
61% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 2.39 vs. LHCG: 1.92 )
Ranked among companies with meaningful P/B only.
LHCG' s P/B Range Over the Past 10 Years
Min: 0.88  Med: 1.96 Max: 4.51
Current: 1.92
0.88
4.51
P/S 0.84
LHCG's P/S is ranked higher than
72% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. LHCG: 0.84 )
Ranked among companies with meaningful P/S only.
LHCG' s P/S Range Over the Past 10 Years
Min: 0.35  Med: 0.84 Max: 2.33
Current: 0.84
0.35
2.33
PFCF 15.13
LHCG's PFCF is ranked higher than
75% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. LHCG: 15.13 )
Ranked among companies with meaningful PFCF only.
LHCG' s PFCF Range Over the Past 10 Years
Min: 3.89  Med: 12.84 Max: 91.68
Current: 15.13
3.89
91.68
POCF 11.33
LHCG's POCF is ranked higher than
66% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 14.12 vs. LHCG: 11.33 )
Ranked among companies with meaningful POCF only.
LHCG' s POCF Range Over the Past 10 Years
Min: 3.67  Med: 10.09 Max: 146.83
Current: 11.33
3.67
146.83
EV-to-EBIT 12.52
LHCG's EV-to-EBIT is ranked higher than
79% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 19.66 vs. LHCG: 12.52 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.8  Med: 9.55 Max: 94.9
Current: 12.52
-80.8
94.9
EV-to-EBITDA 10.55
LHCG's EV-to-EBITDA is ranked higher than
71% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. LHCG: 10.55 )
Ranked among companies with meaningful EV-to-EBITDA only.
LHCG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.8  Med: 8.8 Max: 137.5
Current: 10.55
-74.8
137.5
PEG 0.87
LHCG's PEG is ranked higher than
90% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.64 vs. LHCG: 0.87 )
Ranked among companies with meaningful PEG only.
LHCG' s PEG Range Over the Past 10 Years
Min: 0.26  Med: 0.37 Max: 0.87
Current: 0.87
0.26
0.87
Shiller P/E 26.03
LHCG's Shiller P/E is ranked higher than
56% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 27.06 vs. LHCG: 26.03 )
Ranked among companies with meaningful Shiller P/E only.
LHCG' s Shiller P/E Range Over the Past 10 Years
Min: 13.9  Med: 22.19 Max: 33.85
Current: 26.03
13.9
33.85
Current Ratio 1.83
LHCG's Current Ratio is ranked higher than
70% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. LHCG: 1.83 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.45
Current: 1.83
1.65
4.45
Quick Ratio 1.83
LHCG's Quick Ratio is ranked higher than
75% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. LHCG: 1.83 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.45
Current: 1.83
1.65
4.45
Days Sales Outstanding 48.55
LHCG's Days Sales Outstanding is ranked lower than
59% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. LHCG: 48.55 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.2  Med: 50.41 Max: 85.77
Current: 48.55
46.2
85.77

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.00
LHCG's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. LHCG: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
LHCG' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.5  Med: -0.6 Max: 2
Current: -1
-13.5
2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.08
LHCG's Price/Projected FCF is ranked higher than
72% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. LHCG: 1.08 )
Ranked among companies with meaningful Price/Projected FCF only.
LHCG' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.34  Med: 0.58 Max: 1.19
Current: 1.08
0.34
1.19
Price/Median PS Value 1.01
LHCG's Price/Median PS Value is ranked higher than
55% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 1.00 vs. LHCG: 1.01 )
Ranked among companies with meaningful Price/Median PS Value only.
LHCG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.44  Med: 1.04 Max: 2.78
Current: 1.01
0.44
2.78
Earnings Yield (Greenblatt) (%) 8.06
LHCG's Earnings Yield (Greenblatt) (%) is ranked higher than
84% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. LHCG: 8.06 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
LHCG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.1  Med: 10.05 Max: 25.9
Current: 8.06
1.1
25.9
Forward Rate of Return (Yacktman) (%) -17.36
LHCG's Forward Rate of Return (Yacktman) (%) is ranked lower than
91% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. LHCG: -17.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
LHCG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -17.36  Med: 13.6 Max: 30114.3
Current: -17.36
-17.36
30114.3

More Statistics

Revenue (TTM) (Mil) $898.4
EPS (TTM) $ 1.96
Beta0.75
Short Percentage of Float2.93%
52-Week Range $32.04 - 47.89
Shares Outstanding (Mil)18.18

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 911 952
EPS ($) 2.01 2.15
EPS w/o NRI ($) 2.01 2.15
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
Dividends Per Share ($)
» More Articles for NAS:LHCG

Headlines

Articles On GuruFocus.com
Gurus' Stocks With Negative 3 Months Returns Aug 11 2016 
Intelligent (and Unintelligent) Investing: Part 1 Jun 03 2015 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
LHC Group Reports Operating Results (10-K) Mar 10 2011 
LHC Group Reports Operating Results (10-Q) Nov 03 2010 
LHC Group Reports Operating Results (10-Q) Aug 06 2010 
LHC Group (LHCG) CFO Peter J. Roman sells 1,200 Shares May 27 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 169,800 Shares May 13 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 5,200 Shares May 12 2010 
A Simple Metric to Clarify the Balance Sheet Apr 19 2010 

More From Other Websites
ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up Dec 08 2016
Should You Buy LHC Group, Inc. (LHCG)? Dec 08 2016
Inogen (INGN) Affirms Outlook and Shuffles Top Management Dec 07 2016
CryoLife (CRY) Now a Strong Buy: Should You Add the Stock? Dec 07 2016
athenahealth-ADP Launch Cloud-Based Payroll for Hospitals Dec 07 2016
Allscripts Buys Core Medical Solutions, Expands in Australia Dec 06 2016
Envision Healthcare Ties Up with Alabama Neonatal Medicine Dec 06 2016
DaVita Ties Up With Inspira Health, Expands in South Jersey Dec 05 2016
Should You Get Rid of Amedisys (AMED) Now? Dec 05 2016
3 Reasons Value Stock Investors Will Love LHC Group (LHCG) Nov 30 2016
Top Ranked Growth Stocks to Buy for November 21st Nov 21 2016
New Strong Buy Stocks for November 21st Nov 21 2016
LHC Group, Inc. :LHCG-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Nov 18 2016
LHC GROUP, INC Financials Nov 11 2016
LHC Group to Present at the Stephens 2016 Fall Investment Conference Nov 08 2016
LHC Group, Inc.: Gathering momentum, can it sustain its performance? Nov 04 2016
Edited Transcript of LHCG earnings conference call or presentation 3-Nov-16 3:00pm GMT Nov 04 2016
LHC Group, Inc. breached its 50 day moving average in a Bullish Manner : LHCG-US : November 4, 2016 Nov 04 2016
LHC GROUP, INC Files SEC form 10-Q, Quarterly Report Nov 03 2016
LHC beats Street 3Q forecasts Nov 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)